Different medical institutions have selected different imported and domestic brand instruments: 38 domestic and 58 imported.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Recently,Thermo Fisher Scientific announced that it plans to acquire Mesa Biotech,INC with USD 450 million in cash and a milestone payment of USD 100 million.

HOB Biotech Group (HOB) and Shanghai Liferiver Biotech Co., Ltd. were successfully listed on Shanghai Stock Exchange in January 2021.

HOB Biotech Group (HOB) and Shanghai Liferiver Biotech Co., Ltd. were successfully listed on Shanghai Stock Exchange in January 2021.

January 18, 2021, Pfizer China and Cepheid China formally signed a strategic cooperation agreement in Shanghai.

In January 2021, Beijing Targeting One Biotechnology Co., Ltd. (hereinafter referred to as " Targeting One") announced the completion of 150 million round B financing.

There is a vaccine race, but not between countries. It is a race between humans to develop vaccines and novel coronavirus.

Find out what is going on in Chinese in vitro diagnostic industry.

Recently, Shanghai Runda Medical Technology Co., Ltd. disclosed to the public that the company will acquire part of the shares of two IVD companies in Anhui and Shanghai at a price of 328 million.

Till this report, there are 14 Chinese IVD enterprise successfully developed the B.1.1.7 testing kits.

The State Council Information Office P.R.C.announced that the Sinopharm COVID-19 Vaccine has been approved.